The significant growth of Thermo Fisher Scientific over the past 15 years, as evidenced by a 19.42% average annual return and the increase in investment value from $1000 to $14,579.53, indicates a strong performance and potential for continued positive momentum. This historical performance, coupled with a substantial market capitalization of $213.66 billion, suggests a positive outlook for TMO in the short term.